当前位置: X-MOL 学术South. Afr. J. Hiv Med. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Gestational trophoblastic neoplasm and women living with HIV and/or AIDS.
Southern African Journal of Hiv Medicine ( IF 1.7 ) Pub Date : 2015-07-03 , DOI: 10.4102/sajhivmed.v16i1.344
Pieter Barnardt 1 , Martha Relling 1
Affiliation  

The 2011 World Health Organization global report on HIV and/or AIDS estimated that sub-Saharan Africa comprised 67% of the global HIV burden, with a current estimate of 5.9 million cases in South Africa. Since the introduction of antiretroviral therapy, there has been an increase in the incidence of non-AIDS-defining cancers. Gestational trophoblastic neoplasm (GTN) is a rare pregnancy-related disorder with an incidence ranging from 0.12-0.7/1000 pregnancies in Western nations. The overall cure rate is about 90%. Response to treatment for GTN is generally favourable; but the sequelae of HIV and/or AIDS, the resultant low CD4 counts, comorbidities, poor performance status and the extent of metastatic disease in patients receiving chemotherapy, compromise the prognosis and survival.

中文翻译:

妊娠滋养细胞肿瘤和感染艾滋病毒和/或艾滋病的妇女。

2011年世界卫生组织关于艾滋病毒和/或艾滋病的全球报告估计,撒哈拉以南非洲占全球艾滋病毒负担的67%,目前估计南非有590万例。自从引入抗逆转录病毒疗法以来,非艾滋病定义癌症的发病率有所增加。妊娠滋养细胞肿瘤(GTN)是一种罕见的妊娠相关疾病,在西方国家的发病率范围为0.12-0.7 / 1000怀孕。总体治愈率约为90%。一般而言,对GTN治疗的反应良好;但是,HIV和/或AIDS的后遗症,导致化疗患者的CD4计数低,合并症,不良表现和转移性疾病的程度降低了预后和生存率。
更新日期:2020-08-21
down
wechat
bug